Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
39 studies found for:    Hyperoxaluria
Show Display Options
Rank Status Study
1 Recruiting Primary Hyperoxaluria Mutation Genotyping/Phenotyping
Condition: Primary Hyperoxaluria
Intervention: Other: Genetic Analysis
2 Completed
Has Results
Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
Condition: Hyperoxaluria
Interventions: Drug: Betaine;   Drug: Placebo
3 Withdrawn Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
Condition: Hyperoxaluria
Interventions: Drug: ACEI / Angiotensin converting enzyme inhibitor;   Drug: ARB /Angiotensin Receptor Blocker;   Drug: Placebo
4 Completed Primary Hyperoxaluria Mutation Genotyping
Condition: Primary Hyperoxaluria
Intervention: Genetic: Genetic Analysis
5 Completed Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate
Condition: Primary Hyperoxaluria Type I
Intervention: Drug: Vitamin B 6
6 Completed Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxabact OC5 capsules;   Drug: Placebo capsules
7 Completed Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxalobacter formigenes;   Drug: Placebo
8 Completed
Has Results
Oxazyme in Patients With Hyperoxaluria
Condition: Hyperoxaluria
Intervention: Drug: Oxazyme
9 Recruiting Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
Condition: Primary Hyperoxaluria
Intervention: Biological: Oxalobacter formigenes
10 Active, not recruiting Proteomics of Primary Hyperoxaluria Type 1
Condition: Primary Hyperoxaluria Type 1
Intervention: Other: Observational
11 Active, not recruiting A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
Condition: Primary Hyperoxaluria Type 1
Intervention: Drug: DCR-PH1
12 Completed
Has Results
Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Conditions: Hyperoxaluria;   Nephrolithiasis
Intervention: Drug: ALLN-177
13 Active, not recruiting Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
Conditions: Enteric Hyperoxaluria;   Hyperoxaluria
Intervention: Drug: C-13 labeled oxalate
14 Recruiting Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1
Condition: Primary Hyperoxaluria Type 1 (PH1)
Interventions: Drug: ALN-GO1;   Drug: Sterile Normal Saline (0.9% NaCl)
15 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxabact OC5 - Oxalobacter formigenes HC-1;   Other: Placebo
16 Completed Phase 2/3 Oxabact Study
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxalobacter formigenes;   Drug: Placebo
17 Active, not recruiting Hydroxyproline Influence on Oxalate Metabolism
Condition: Hyperoxaluria
Intervention: Drug: Hydroxyproline and Leucine
18 Completed Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
Conditions: Secondary Hyperoxaluria;   Nephrolithiasis;   Hyperoxaluria;   Kidney Stones;   Dietary Hyperoxaluria
Interventions: Drug: ALLN-177;   Drug: Placebo
19 Withdrawn International Registry for Primary Hyperoxaluria
Conditions: Primary Hyperoxaluria;   Nephrocalcinosis;   Kidney Stones
Intervention:
20 Completed Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
Conditions: Secondary Hyperoxaluria;   Nephrolithiasis;   Kidney Stones;   Hyperoxaluria;   Dietary Hyperoxaluria
Interventions: Drug: ALLN-177 low dose;   Drug: ALLN-177 mid dose;   Drug: ALLN-177 high dose;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.